Wellstar Recognized as Cancer Treatment Leader

Wellstar Health System is recognized as one of the best companies to work for in the country for the fourth time; People-centric programs, benefits, and culture foster an inclusive, team-based workplace 

Great Place to Work® and Fortune have honored Wellstar Health System, one of the largest and most integrated healthcare systems in Georgia, as one of the 100 Best Companies to Work For®. This is Wellstar’s fourth time on this prestigious, national list. Wellstar is the only Georgia-based healthcare company included in the 2021 ranking; only two other companies headquartered in Georgia were included in this year’s list.

“In a year of immeasurable challenges, our Wellstar team members and caregivers have remained focused on our mission to enhance the health and well-being of everyone we serve,” said Candice L. Saunders, president and CEO, Wellstar Health System. “Earning the 100 Best Companies to Work For award is a testament to their bravery and unwavering commitment to providing people-centric care for millions of Georgians.”

The Fortune 100 Best Companies to Work For® award is based on analysis of survey responses from more than half a million current employees across the U.S. In that survey, 79% of Wellstar’s employees said Wellstar is a great place to work. By comparison, the average percentage of employees in the U.S. who say their company is a great place to work is only 59%.

"Offering the resources, support, and workplace culture team members need to be their best benefits everyone and everything we do,” said David Jones, executive vice president and chief human resources officer, Wellstar Health System. “We care for our employees so they can care for our community. We are grateful for the recognition from Fortune and, especially, for the all the people who make Wellstar a great place to work.”

While Wellstar’s expert cancer specialists are well-equipped to help their patients fight cancer, they’re also dedicated to stopping cancer before it starts.  

Part of preventing cancer is knowing your risk and taking action early. Wellstar’s Genetic Risk Assessment Program helps patients determine whether they may be at higher risk for some cancers.  

At Wellstar, our focus is PeopleCare: personalized healthcare tailored just for you. For cancer care, that means taking a close look at what makes you unique — your distinct genetic makeup that sets you apart. Genetic counselors use a compassionate approach to guide patients and their families so they can make informed healthcare decisions. 

“We are the busiest genetic counseling program in Georgia,” said Dr. Michael Andrews, Wellstar’s chief cancer officer. “Cancer care now is very genetically-based, and the specialists in our program can look for certain abnormalities and adapt treatments based on what they find.” 

Halting Hereditary Cancers

Genetic mutations play a major role in about 5 to 10% of cancers. A patient with a family history of cancer who learns they have specific genetic mutations can partner with their provider to be more proactive, whether that involves screening, lifestyle changes or medical treatments. Taking a few proactive steps could prevent cancer, even if the patient’s genetics may put them at a higher risk.  

Genetic testing can also benefit cancer patients and empower their whole families with important information. If a cancer patient learns they carry a mutation, it can help relatives decide if they could benefit from genetic testing. Also, people who have certain cancers and also have specific DNA sequences may benefit from targeted therapies. 

Some possible signs of hereditary cancer include: 

• Unusually early age of cancer onset
• Multiple primary cancers in a single patient
• Cancer in paired organs (such as in cancer in both breasts)
• Multi-generational cancers
• Rare tumors
• An unusual presentation, such as male breast cancer
• Belonging to an ethnic group known to be at high risk for hereditary cancers
• No environmental explanation for the cancer

Some gene mutations can increase your cancer risk, so if your provider finds that you are affected, they may recommend increased screenings and other precautions to monitor your health. 

• TP53: This gene produces a protein that slows down tumor growth. Mutations in this gene can cause Li-Fraumeni syndrome, which puts patients at an increased risk for developing some cancers. 
• BRCA1 and BRCA2: Mutations in these genes increase the risk of breast and ovarian cancer, as well as pancreatic cancer, prostate cancer and male breast cancer.
• PTEN: This gene also stops tumor growth. Mutations in this gene are associated with Cowden syndrome, a disorder that increases the risk of breast, thyroid, endometrial and other forms of cancer. 

Take charge of your health — and maybe help out a family member, too — by learning more about how your genetics could affect your cancer risk. Call (470) 793-7472 to book an appointment with a Wellstar genetic counselor. Both in-person and virtual visits are available. Learn more at wellstar.org/cancercare.

Wellstar and Delta Sigma Theta, Inc., the largest African American women's organization in the world with more than 350,000 college-educated members, have united to reach vaccine-reticent populations in Georgia by sharing personal “My Why” stories and reasons for receiving the COVID-19 vaccine.

Who: Beverly E. Smith, national president and CEO of Delta Sigma Theta Sorority, Inc., joined Wellstar team members in sharing a personal reflection about receiving the COVID-19 vaccine. A recent poll found that Black voters in Georgia are less sure about vaccine safety than another racial or ethnic group, with 36 percent reporting that they are unsure if the vaccine is safe or not. The video aims to tackle these concerns and offer hope for the future as more Georgians become fully vaccinated. Delta Sigma Theta Sorority Inc. national president and CEO, Beverly E. Smith, joins Wellstar team members in sharing a personal reflection about receiving the COVID-19 vaccine.